CRISPR/Cas9-Mediated Allele-Specific Disruption of a Dominant COL6A1 Pathogenic Variant Improves Collagen VI Network in Patient Fibroblasts

por López-Márquez, Arístides, Morín, Matías, Fernández-Peñalver, Sergio, Badosa, Carmen, Hernández-Delgado, Alejandro, Natera-de Benito, Daniel, Ortez, Carlos, Nascimento, Andrés, Grinberg, Daniel, Balcells, Susanna, Roldán, Mónica, Moreno-Pelayo, Miguel Ángel, Jiménez-Mallebrera, Cecilia
Publicado 2022

Therapeutic Potential of EWSR1–FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma

por Cervera, Saint T., Rodríguez-Martín, Carlos, Fernández-Tabanera, Enrique, Melero-Fernández de Mera, Raquel M., Morin, Matias, Fernández-Peñalver, Sergio, Iranzo-Martínez, Maria, Amhih-Cardenas, Jorge, García-García, Laura, González-González, Laura, Moreno-Pelayo, Miguel Angel, Alonso, Javier
Publicado 2021